ESR1 and breast cancer: AJCC prognostic stage is a key prognostic factor in BC, showing a highly accurate outcome prediction often combined with other biological variables, such as progesterone (PR) and/or estrogen receptor (ER) status, as well as HER2 status and tumor grade [42].